New obesity drug spartina® tested in real-world study
NCT ID NCT07262762
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study is testing a drug called Spartina® (Tirzepatide) to see if it helps people with obesity or overweight lose weight safely. About 175 adults will take the drug and be monitored for weight loss and side effects. There is no placebo group — everyone gets the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY; OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Akbar Aliasgarzadeh Clinic
RECRUITINGTabriz, East Azerbaijan Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Alireza Esteghamati clinic
RECRUITINGTehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Behrang Motamed Clinic
RECRUITINGRasht, Gilan Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dr. Mohammadhossein Dabbaghmanesh Clinic
RECRUITINGShiraz, Fars, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Farzad Hadaegh Clininc
RECRUITINGTehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hajieh Bibi Shahbazian Clinic
RECRUITINGAhvāz, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Imam Khomeini Hospital
RECRUITINGTehran, Tehran Province, Iran
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Iran University Endocrinology Research Center
RECRUITINGTehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Khorshid Clinic
RECRUITINGYazd, Yazd Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mansoor Siavash Dastjerdi Clinic
RECRUITINGIsfahan, Isfahan, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mohammadreza Mohajeri Tehrani Clininc
RECRUITINGTehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sari Diabetes Research Center
RECRUITINGSari, Mazandaran, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seyed Mojtaba Mehrdad Clinic
RECRUITINGRasht, Gilan Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shokoofeh Bonakdaran Clininc
RECRUITINGMashhad, Razavi Khorasan Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.